Point72 Asia (Singapore) Pte. Ltd. Guardant Health, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $381 Billion
- Q1 2025
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 8,747 shares of GH stock, worth $437,262. This represents 0.1% of its overall portfolio holdings.
Number of Shares
8,747
Previous 2,004
336.48%
Holding current value
$437,262
Previous $61.2 Million
508.62%
% of portfolio
0.1%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding GH
# of Institutions
393Shares Held
121MCall Options Held
1.43MPut Options Held
2.37M-
Vanguard Group Inc Valley Forge, PA12.1MShares$604 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$562 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.44MShares$272 Million8.11% of portfolio
-
Capital International Investors Los Angeles, CA5.15MShares$257 Million0.04% of portfolio
-
Baillie Gifford & CO5.06MShares$253 Million0.19% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $5.11B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...